BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10897217)

  • 1. [Expression of recombinant human dihydropyrimidine dehydrogenase and its application to the preparation of anti-DPD antibodies for immunochemical detection].
    Okabe H; Arakawa K; Takechi T; Fukushima M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):891-8. PubMed ID: 10897217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of anti-OPRT antibody for immunochemical detection].
    Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
    Gan To Kagaku Ryoho; 2005 May; 32(5):653-8. PubMed ID: 15918566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dihydropyrimidine dehydrogenase expression in gastric cancer using anti-human dihydropyrimidine dehydrogenase monoclonal antibody].
    Kitago K; Ichikawa W; Uetake H; Nihei Z
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):245-52. PubMed ID: 11865631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody.
    Tokunaga Y; Nakagami M; Tokuka A; Ohsumi K
    Anticancer Res; 2003; 23(2C):1763-8. PubMed ID: 12820455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells.
    Sakamoto K; Sugimoto Y; Miyadera K; Oka T; Fukushima M
    Int J Mol Med; 2005 Aug; 16(2):245-9. PubMed ID: 16012756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine against non-small cell lung cancer--in correlation with the tumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Inoue K; Takao M; Watanabe F; Tarukawa T; Shimamoto A; Kaneda M; Sakai T; Fukushima M; Shimpo H; Yada I
    Lung Cancer; 2005 Jul; 49(1):47-54. PubMed ID: 15949589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.
    Li Y; Mizutani Y; Shiraishi T; Nakamura T; Mikami K; Takaha N; Okihara K; Kawauchi A; Sakai T; Miki T
    BJU Int; 2007 Mar; 99(3):663-8. PubMed ID: 17092280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
    Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
    Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells.
    Takebe N; Zhao SC; Ural AU; Johnson MR; Banerjee D; Diasio RB; Bertino JR
    Cancer Gene Ther; 2001 Dec; 8(12):966-73. PubMed ID: 11781659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of immunohistochemical evaluation of dihydropyrimidine dehydrogenase for rectal cancer treated with preoperative radiotherapy.
    Komuro Y; Watanabe T; Tsuno N; Kitayama J; Inagaki N; Nishida M; Nagawa H
    Hepatogastroenterology; 2003; 50(52):906-11. PubMed ID: 12845947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Takahashi K; Saito T
    Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of dihydropyrimidine dehydrogenase gene expression in regenerating mouse liver.
    Yamada H; Fukushima M; Koizumi K; Katakura H; Nakanishi H; Teshima S; Kamiyama Y; Ikenaka K
    Int J Oncol; 2003 Feb; 22(2):359-64. PubMed ID: 12527935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of immunoreactivity of dihydropyrimidine dehydrogenase (DPD) in gastric scirrhous carcinoma treated with S-1, a new DPD inhibitory fluoropyrimidine.
    Shimizu T; Yamada Y; Yasui H; Shirao K; Fukuoka M
    Anticancer Res; 2005; 25(4):2997-3001. PubMed ID: 16080558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues.
    Kurebayashi J; Yamamoto Y; Udagawa K; Okubo S; Fukushima M; Sonoo H
    Oncol Rep; 2004 May; 11(5):973-9. PubMed ID: 15069534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine dehydrogenase expression in preoperative biopsy and surgically resected specimens of gastric carcinoma.
    Nozawa H; Tsukui H; Nishida K; Yakumaru K; Nagawa H; Sekikawa T
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):267-73. PubMed ID: 11914904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
    Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
    J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer].
    Ishida H; Ohsawa T; Nakada H; Yokoyama M; Inokuma S; Shirakawa K; Yamada H; Hashimoto D
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):883-7. PubMed ID: 15222105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.